Supply chain vulnerabilities and strategic concerns for India's pharmaceutical industry amid Hormuz crisis
India, May 31 -- As global geopolitical tensions continue to rise, ensuring resilience in interconnected systems
India's pharmaceutical industry occupies a critical place in the global healthcare system. Often referred to as the "pharmacy of the world," India is one of the largest producers of generic medicines and supplies affordable drugs to both developed and developing nations. With thousands of WHO-GMP-approved manufacturing units and a strong export network, Indian medicines reach nearly every part of the globe. Countries across Africa, Asia, Europe, and even the United States depend heavily on Indian pharmaceutical products for essential healthcare needs. However, the recent disruption in the Strait of Hormuz has exposed a major v...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.